Doctor N.E. Chernobayev
+7 (921) 657-60-44
Items in cart: 0
to the amount of: 0 руб.
Proceed to checkout
Ask a question

For patients

 

 The preparation of highly dispersed camphora emulsion distributed under the trademark Ecado, which is offered to you hereby, is manufactured using a special technology and based on an excellent carriers, which provide for its rapid absorption. It should outlined from the very start that this is neither a homeopathic preparation nor food additive. ECADO is a genuine pharmaceutical with a proved mechanism of action and elaborate formulation.

Camphora has been being used in medicine for more than 100 years. At the beginning of the XX century, it was used very broadly and was unmatched in many respects. There was even a refined phrase in use among physicians: to camphor a patient. Treated with camphora were common cold, pneumonia, cardiac asthma, infarctions, and their sequelae as well as complications of stroke. This treatment proved to be not bad at all.  

I remember lectures in surgery given by Prof. Zhitniuk: "V.I. Lenin, after having been shooted, suffered from total leftside hemothorax so that the entire left side of his thorax was filled with blood. If the effused blood did not clot, the patient would have inevitably died. He was not operated, drained or punctured. However, blood did not clot, it just resolved, because he was camphored."

Camphora is among a few drugs that have been studied exhaustively in many countries. However, strange as it is, it was never used against prostate adenoma, prostatitis, impotence or infertility. These are the diseases to be treated by the newly developed preparation ECADO. It has no analogues in the world. The discovery of its novel use has been patented.  

After an age of about 23-35 years, men start to develop notable alterations in the prostate. After this age, signs of prostatitis are usually found upon visits to doctors. About 30-45% of men older than 35 years already suffer from chronic prostatitis, and 40-80% of them experience impairments in the copulative function. What is this caused by? The prostate is an internal sex male organ producing a specific secretion. This secretion has to be released at an amount about 5 mL daily. This secretion is either included in sperm or, where no regular coituses occur, is excreted with urine upon urination. As age increases, the secretion thickens, and the prostate becomes emptied incompletely. Any human tissue, including blood, urine, and even bone, is a biocolloid vulnerable to natural "aging", colloidoclasia. Aged prostate secretion acquires altered physicochemical properties including viscosity increased above normal values. The prostate generates its secretion perpetually; therefore, its glands (acini) become filled and stretched by their thick secretion. In this way, congestive prostatitis develops. This is a natural process for an aging colloidal system. (Imagine a flask with sower milk on a windowsill. After a fortnight, the flask will contain whey above and a layer of clotted milk below). Subsequently, the remainders of the secretion undergo further changes, and in a few years an adenomatous node develops. It is currently believed that prostate adenoma is inevitable for every man. The preparation ECADO is rapidly absorbed, and camphora, which is comprised by it, is secreted by the prostate and promotes liquefaction of its secretion. The congested secretion is rapidly excreted. Its natural viscosity and bactericidal activity becomes restored. The use of ECADO rapidly promotes the resistance of the secretion to aging. Over body lifespan, body colloids undergo changes including thickening, increasing viscosity, and decreasing resistance to harmful factors. These are the general features of any aging colloidal system. The effects of ECADO are considered, first of all, from the standpoint of colloid protection. There exist substances that counteract this process of aging. One of such substances possessing high surface activity is low molecular weight camphora comprised by ECADO according to its "golden" proportion. It is only later that the congestive prostatitis may become associated with an infection and develop into the bacterial prostatitis. The ratio of the rates of congestive and bacterial prostatitis is 15:1. ECADO possesses an expressed bactericidal activity. A short-term influence of the preparation on the prostate easily eliminates all pathogenic microflora therein. The preparation is active against gram-negative and gram-positive microflora, pyogenic microflora being most sensitive to it. Numerous investigations into the causes of prostatitis provided reasons to disregard fungi, trichomonas, viruses, mycoplasma, ureaplasma and chlamydia as etiological factors. 

Results obtained in patients treated for prostate adenoma with ECADO are very good. The preparation provides for a decrease in prostate adenoma by 30-35% on average in a very short time. Such results were never achieved with other preparations. A very demonstrative example is patient G, born in 1926, whose ultrasonographic images are shown here. His prostate size decreased by 50% in two months. The images are provided so as to show the inborn bladder diverticulum proving that these are the images taken from one and the same patient (see photo).  

Prostatitis treatment with ECADO is as easy as it can be. Abstinence from alcohol and species are mandatory during treatment. Treatment courses should be repeated 3-4 times annually and last for 20-40 days (two packages).

The above relates to prostatitis and its direct consequence, prostate adenoma. Now I will explain how ECADO restores full-blown erection and influences the duration of coitus. It is known from ancient times that humans have the so-called parasympathetic nervous system, which is comprised of two parts. One of the parts is in the brain (pars cranialis). Here the respiratory and vasomotor centers are located. Camphora influences these centers so as to induce zonal excitation there resulting in vasodilation within the brain, heart, lungs, and bronchi. The second part of the parasympathetic nervous system is located much lower, in the sacral segment of the spine (pars sacralis) where the center of erection is located. The mechanism of action of ECADO on these two parts is the same. ECADO causes zonal excitation in the center of erection resulting in the dilation of the cavernous bodies of the penis. The effectiveness of the preparation against premature ejaculation is explained by its blocking effect on nerve projections from ejaculation center to the penis. To date, ECADO is the first neuromodulator of erection acting immediately on the sacral center. It affords a balanced modification of the functional state of the erection center of the parasympathetic nervous system that is featured by different diseases.

The preparation ECADO is used in clinical practice for more than 15 years. Treatment procedures are very comfortable and easy for patients. Its use makes it possible to exclude other auxilliary treatments, physiotherapeutic procedures, and massage of the prostate. Over years, 12 thousand patients passed the treatment. I do not remember even a single case where the use of ECADO did not result in a pronounced positive effect. By now, I can without hesitation prescribe ECADO for erectile dysfunction being firmly sure before hand that everything will be all right without my further involvement. A demonstrative example, in this respect, is the case of a patient born in 1914 who complained in 2004 about incomplete erection. He motivated the need to be treated by his desire to marry a 55-years old woman.  He was provided with my preparation. My next meeting with him was in one year, in summer 2005.

The patient insisted on using the preparation once again for 20 days. We had a talk, and he told me that he is all right, his erection is full, and his wife is satisfied.

You have probably read this and though that everything is that easy. It is not so easy actually. I am often asked about how I guessed about this treatment?  It seems as if it was a glance from behind a looking glass.

During more that 15 years of using ECADO in treating of patients having sperm pathology, 42 men were treated to result in 37 pregnancies (!!!). Below is a table picked up from the book by R.J. Pepperel about different therapies for sperm pathology used by different authors.

Treatment

Number of patients

Number of pregnancies

Mesterolone

48

5

Response to testosterone

25

4

Chorionic gonadotropin

9

1

Clomifen

22

2

Bromocriptin

24

2

Antibiotics

41

8

No treatment

115

33

Ecado

42

37

The experience of experts in urology and their thorough studies and analytical generalizations make it indisputable that 35-40% of men above 35 years of age suffer from chronic prostatitis. In 40-80% of prostatitis patients, their copulative function is impaired. Probably, such alterations are naturally programmed and inevitable. First, prostatitis and then, as a result, prostate adenoma (BPH) develops. After 80 years, prostate adenoma is present in 95.5% of men [Portnoy, 1979]. I believe, that these are the links of the same chain of events of the natural aging. How can one prevent the development of this pathological process from prostatitis to prostate adenoma (BPH)? In my preventive program, I put emphasis on patient's age. This is the world first preventive program. Two formulations of ECADO are used in it. The most bioavailable and effective is the highly dispersed camphora emulsion, which is recommended for the main treatment course, whereas rectal suppositories with camphora are recommended as a long-term supportive therapy following the main treatment course.

The program for prevention of chronic prostatitis, benign prostate hyperplasia, erectile dysfunction, and prostate cancer is as the following.

1.         Age: 35-40 years.

Symptoms: may be inapparent.

Duration: Camphora emulsion daily by night for 20-40 days (1-2 packages). Supportive therapy: rectal suppositories with camphora, courses of 20 to 40 days (1-2 packages) once or twice annually.

Recommendation:

  • - urine test;
  • - blood test;
  • - ultrasonography;
  • - palpation of the prostate; and
  • - spermogram (compare with earlier results).

2.         Age: 40-50 years.

The first signes of the disease appear, including the sensations of heaviness in the perineum, hyperhidrosis of the scrotum, decreased urine pressure, and nocturnal urination about once per night. Decreased urine pressure may occur periodically. Premature ejaculation and incomplete or unstable erection develop.

Treatment duration: daily for 20-40 days (1-2 complects) every year. Supportive therapy: rectal suppositories with camphora for 20-40 days daily (1-2 packages) 1-2 time annually.

Recommendations:

  • - urine test;
  • - blood test;
  • - PSA;
  • - ultrasonography;
  • - palpation of the prostate and
  • - spermogram (compare it with earlier results).

3.   Age 50-55 years or more.

At this age, overt manifestations of the disease are possible, including frequent urination, especially at night - more that two times, diurnal "WC-bound" condition, weak jet of urine, the need to press out urine by the end of urination, morning aching and heaviness in the perineum and pain above the pubic area, incomplete and unstable erection, and premature ejaculation.  

Treatment duration: every day by night for 2-3 months each year (2-3 packages). Supportive therapy: rectal suppositories with camphora by courses of 20-40 days minimum (1-2 packages) one to two times annually.

Recommendations:

  • - urine tests;
  • - blood tests;
  • - blood sugar;
  • - bilirubin;
  • - creatinine;
  • - ultrasonography;
  • - PSA; and
  • - palpation of the prostate


You may define your attitude to the new level of life quality resulting from using ECADO and express it using the International prostate symptom score (IPSS)

 

 

Not at all

Less than 1 time in 5

Less than half the time

About half the time

More than half the time

Almost always

1. Incomplete emptying
Over the past month, how often have you had a sensation of not emptying your bladder completely after you finish urinating?

0

1

2

3

4

5

2. Frequency

Over the past month, how often have you had to urinate again less than two hours after you finished urinating?

0

1

2

3

4

5

3. Intermittency

Over the past month, how often have you found you stopped and started again several times when you urinated?

0

1

2

3

4

5

4. Urgency

Over the last month, how difficult have you found it to postpone urination?

0

1

2

3

4

5

5. Weak stream

Over the past month, how often have you had a weak urinary stream?

0

1

2

3

4

5

5. Straining

Over the past month, how often have you had to push or strain to begin urination?

0

1

2

3

4

5

6. Nocturia
Over the past month, many times did you most typically get up to urinate from the time you went to bed until the time you got up in the morning?

0

1

2

3

4

5

 

Total IPSS score

 

Quality of life due to urinary symptoms

Delighted

Pleased

Mostly

satisfied

Mixed - about equally satisfied and dissatisfied

Mostly dissatisfied

Unhappy

Terrible

If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?

0

1

2

3

4

5

6


Using the IPSS scores, symptoms are referred to three categories: 0-7 mild; 8-19 moderate; 20-35 severe. Numerous studies have shown that such parameters, as maximal urine stream, residual urine, prostate size, and intravesicular obstruction, poorly correlate with IPSS scores [6,7]. Therefore, indications for surgery cannot be defined using this approach only. However, IPSS adequately reflects the impact of the disease on life quality.

ECADO is available as two formulations: highly dispersed camphora and rectal suppositories.

Both formulations are highly potent and safe.

Highly dispersed emulsion (ECADO)

Indications: Stage 1 and 2 adenoma of the prostate; chronic prostatitis; male infertility, sexual failure, prostate cancer prevention

Contraindications: epilepsy, glaucoma, individual intolerability.

Side effects: local reactions, which are manifested as mild itching, ares possible in some cases

Dosages and application procedures: The usual dose is 4-5 mL of emulsion. The preparation is introduced into the rectum daily before sleep. For this, the piston is pulled out of  the syringe, and the syringe is filled with the emulsion up to the mark of 5 mL. The piston is inserted, and the tip is lubricated and inserted into the anus as far as the limiter allows. The contents of the syringe is pressed out. Thr syringe is washed with warm water and soap. The procedures are carried out daily over 2 months for chronic prostatitis, 3 months for prostate adenoma, and 2 to 6 months for infertility. In the cases of erectile dysfunction, the preparation should be applied 30 minutes before the anticipated sexual contact. Upon daily usage 1 time a day by patients above 75 years of age, the optimal time for response to the preparation may be protracted up to 75 h. It is recommended to use the preparation further for up to 2 months to fully develop its specific activity. Coitus duration becomes restored in a short time. No other influences on the prostate are required. The need for physiotherapy, massage of the prostate, and other medicaments is completely eliminated.

Note: the preparation shall not be used after its expiry date. Store it in a dry cool place protected from light.

Shelf life: two years.

Package content: three 45-mL tubes, enema syringe, instruction. (Check package integrity)

The preparation is used upon prescription provided by urologist Dr. Chernobayev.

Copyright owner of the formulation is N.Ye. Chernobayev. The copyright is protected by RF laws on author rights and intellectual property.

Manufactured by MPP Farmatsiya (Saint-Petersburg) by author's license.

The preparation is not subject to state registration and certification.

The price of one complect of ECADO emulsion is 300 USD.

Rectal suppositories with camphora (ECADO)

These rectal suppositories are handmade based on cacao oil so as to contain camphora. The manufacture process is carried out by best specialists in Saint-Petersburg using a special technology.

Indications: Stage 1 or 2 adenoma of the prostate, chronic prostatitis,male infertility, erectile dysfunction, premature ejaculation, prostate cancer prevention.

Contraindications: epilepsy, glaucoma, individual intolerability.

Usage terms: In chronic prostatitis, the preparation is used by courses of 20 to 40 days (2 packages) once or twice annually depending on patient's condition: for benign hyperplasia of the prostate, the suppositories are used by courses of 20-40 days (1-2 packages) 2 to 4 times annually; for erectile dysfunction and premature ejaculation, the suppositories are used by courses of 20-40 days (1-2 packages) depending on patient's condition. For preventive purposes, the suppositories are used by courses of 20 days (1 package) or longer. From one to three such courses are recommended.

Note: store the preparation in a dry, cool, dark place at 12-15°C and protect it from children.

Shelf life: two years.

Package content: 20 suppositories in waxed paper, instruction.

Copyright owner of the formulation is N.Ye. Chernobayev. The copyright is protected by RF laws on author rights and intellectual property.

Manufactured by MPP Farmatsiya (Saint-Petersburg) by author's license.

The preparation ECADO is manufactured by author's (magistral) formulation and is not subject to state registration and certification (based on Rules of Medicinal Drug Registry in Russia, Item 4).

The price of one package with Ecado suppositories is 200 USD.

Patient's Application for treatment

Patient's application for treatment should contain the following optional information: surname, name and patronymic, age, marital status, occupation, home address, telephone number, clinical (laboratory, instrumental) data, previous treatment (surgery or drug therapy), previously used drugs, concomitant diseases.

The private counselling office ECADO is open to any man irrespective of age and residence. Our contact information is here

Rambler's Top100
For patients